513 results on '"Huber, Rudolf M."'
Search Results
102. MUC5AC and MUC5B Mucins Are Decreased in Cystic Fibrosis Airway Secretions
103. Improvement of Alveolar Glutathione and Lung Function but Not Oxidative State in Cystic Fibrosis
104. Three-Dimensional In Vitro Cocultivation of Lung Carcinoma Cells with Human Bronchial Organ Culture as a Model for Bronchial Carcinoma
105. Leitlinie : Empfehlungen der Fachgesellschaft zur Diagnostik und Therapie h��matologischer und onkologischer Erkrankungen
106. Continuous professional development: elevating thoracic oncology education in Europe
107. Interdisciplinary multimodality management of stage III nonsmall cell lung cancer
108. SHERLOC: A phase 2 study of MM-121 plus with docetaxel versus docetaxel alone in patients with heregulin (HRG) positive advanced non-small cell lung cancer (NSCLC).
109. Disease progression in non-small cell lung cancer on immune-checkpoint inhibition, what are the options?
110. Defining aggressive or early progressing nononcogene-addicted non-small-cell lung cancer: a separate disease entity?
111. Successful Treatment of a Patient With NSCLC Harboring an EGFR Mutation and a Concomitant Met Exon 14 Skipping Mutation Combining Afatinib and Crizotinib
112. High blood pressure, antihypertensive medication and lung function in a general adult population
113. Adrenomedullin: A Player at High Altitude?
114. Lung diffusing capacity for nitric oxide and carbon monoxide in relation to morphological changes as assessed by computed tomography in patients with cystic fibrosis
115. Endoplasmic reticulum Ca2+-homeostasis is altered in small and non-small cell lung cancer cell lines
116. In-vivo kinetics of inhaled 5-Aminolevulinic acid-Induced Protoporphyrin IX fluorescence in bronchial tissue
117. Ca2+-signaling in airway smooth muscle cells is altered in T-bet knock-out mice
118. Sequential chemo- and radiochemotherapy with weekly paclitaxel (Taxol®) and 3D-conformal radiotherapy of stage III inoperable non-small cell lung cancer: Results of a dose escalation study
119. Transfer factor for carbon monoxide in patients with COPD and diabetes: results from the German COSYCONET cohort
120. Leitlinie - ICD10: C34.- : Empfehlungen der Fachgesellschaft zur Diagnostik und Therapie hämatologischer und onkologischer Erkrankungen
121. The Potential of Combined Immunotherapy and Antiangiogenesis for the Synergistic Treatment of Advanced NSCLC
122. Flexible bronchoscopy: a safe method for metal stent implantation in bronchial disease
123. Retrospective analysis of treatment with Ivacaftor/Lumacaftor in patients with cystic fibrosis at the Munich Cystic Fibrosis Centers
124. Uric acid, lung function, physical capacity and exacerbation frequency in patients with COPD: a multi-dimensional approach
125. Exploratory Analysis of Brigatinib Activity in Patients With Anaplastic Lymphoma Kinase-Positive Non–Small-Cell Lung Cancer and Brain Metastases in Two Clinical Trials
126. Abstract B17: Interleukin-17 and -22 expression in non-small cell lung cancer
127. Characteristics and treatment of new-onset arthritis after checkpoint inhibitor therapy
128. Response to checkpoint inhibition in lung cancer with molecular driver alterations.
129. Brigatinib (BRG) in crizotinib (CRZ)-refractory ALK+ non–small cell lung cancer (NSCLC): Efficacy updates and exploratory analysis of CNS ORR and overall ORR by baseline (BL) brain lesion status.
130. Safety evaluation of nivolumab added concurrently to radiotherapy in a standard first line chemo-RT regimen in unresectable locally advanced NSCLC: The ETOP NICOLAS phase II trial.
131. Relationship of spirometric, body plethysmographic, and diffusing capacity parameters to emphysema scores derived from CT scans
132. Pretherapeutic Inflammation Predicts Febrile Neutropenia and Reduced Progression-Free Survival after First-Line Chemotherapy in SCLC
133. Perception of climate change in patients with chronic lung disease
134. Relationship of hyperlipidemia to comorbidities and lung function in COPD: results of the COSYCONET cohort
135. Disease-specific medication, patient-reported diagnoses and their relation to COPD severity for common comorbidities in COPD
136. Brigatinib in Patients With Crizotinib-Refractory Anaplastic Lymphoma Kinase–Positive Non–Small-Cell Lung Cancer: A Randomized, Multicenter Phase II Trial
137. Assessment of lung function in a large cohort of patients with acromegaly
138. Brigatinib (BRG) in patients (pts) with crizotinib (CRZ)-refractory ALK+ non-small cell lung cancer (NSCLC) and brain metastases in the pivotal randomized phase 2 ALTA trial.
139. Brigatinib (BRG) in crizotinib (CRZ)-refractory ALK+ non-small cell lung cancer (NSCLC): Updates from ALTA, a pivotal randomized phase 2 trial.
140. Kleinzelliges Lungenkarzinom
141. Relevance of PD-L1 expression status in thymic malignancies
142. Cancer vaccination causes prolonged FDG accumulation in subcutaneous tissue
143. Relationship of spirometric, body plethysmographic, and diffusing capacity parameters to emphysema scores derived from CT scans.
144. Distinct computed tomography features of non-small-cell lung cancer in a European population with EML4-ALK translocation
145. Symptoms and quality of life in relation to lung function and comorbidities in patients with idiopathic pulmonary fibrosis: INSIGHTS-IPF registry
146. Thoracic oncology HERMES: European curriculum recommendations for training in thoracic oncology
147. From diagnosis to therapy in lung cancer: management of CT detected pulmonary nodules, a summary of the 2015 Chinese-German Lung Cancer Expert Panel
148. Interactions among Lung Cancer Cells, Fibroblasts, and Macrophages in 3D Co-Cultures and the Impact on MMP-1 and VEGF Expression
149. Brigatinib (BRG) in patients (pts) with crizotinib (CRZ)-refractory ALK+ non-small cell lung cancer (NSCLC): First report of efficacy and safety from a pivotal randomized phase (ph) 2 trial (ALTA).
150. Activity of brigatinib (BRG) in crizotinib (CRZ) resistant patients (pts) according to ALK mutation status.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.